Business Description
Shandong Wohua Pharmaceutical Co Ltd
NAICS : 325411
SIC : 2834
ISIN : CNE000001QB8
Share Class Description:
SZSE:002107: Class ACompare
Compare
Traded in other countries / regions
002107.China IPO Date
2007-01-24Description
Shandong Wohua Pharmaceutical Co Ltd is a China-based company specializing in the field of cardio-cerebral vascular medicine. The company's main products consist of Xinkeshu tablets for the treatment of coronary heart disease; Naoxueshu oral liquid, promoting blood circulation by removing blood stasis; Hupo Xiaoshi granules for the treatment of urethral calculus, and Yuandu granules for the treatment of influenza, among others.
Financial Strength
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 3763.91 | |||||
| Equity-to-Asset | 0.69 | |||||
| Interest Coverage | 1056.41 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | 7.48 | |||||
| Beneish M-Score | -3.13 | |||||
| WACC vs ROIC | ||||||
Growth Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -3.9 | |||||
| 3-Year EBITDA Growth Rate | -30.1 | |||||
| 3-Year EPS without NRI Growth Rate | -29.9 | |||||
| 3-Year FCF Growth Rate | -4.5 | |||||
| 3-Year Book Growth Rate | -0.1 |
Momentum Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 67.22 | |||||
| 9-Day RSI | 61.34 | |||||
| 14-Day RSI | 60.52 | |||||
| 6-1 Month Momentum % | 7.76 | |||||
| 12-1 Month Momentum % | -27.68 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.1 | |||||
| Quick Ratio | 1.65 | |||||
| Cash Ratio | 1.28 | |||||
| Days Inventory | 226.78 | |||||
| Days Sales Outstanding | 33.69 | |||||
| Days Payable | 91.99 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 4.88 | |||||
| Dividend Payout Ratio | 6.1 | |||||
| Forward Dividend Yield % | 4.88 | |||||
| 5-Year Yield-on-Cost % | 4.88 | |||||
| Shareholder Yield % | 5.12 |
Profitability Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 71.8 | |||||
| Operating Margin % | 3.98 | |||||
| Net Margin % | 3.15 | |||||
| FCF Margin % | 13.04 | |||||
| ROE % | 3.21 | |||||
| ROA % | 2.24 | |||||
| ROIC % | 3.12 | |||||
| ROC (Joel Greenblatt) % | 8.43 | |||||
| ROCE % | 3.92 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 128 | |||||
| PE Ratio without NRI | 124.88 | |||||
| Shiller PE Ratio | 28.44 | |||||
| Price-to-Owner-Earnings | 568.89 | |||||
| PEG Ratio | 49.95 | |||||
| PS Ratio | 3.88 | |||||
| PB Ratio | 4.3 | |||||
| Price-to-Tangible-Book | 4.79 | |||||
| Price-to-Free-Cash-Flow | 27.75 | |||||
| Price-to-Operating-Cash-Flow | 26.73 | |||||
| EV-to-EBIT | 82.99 | |||||
| EV-to-EBITDA | 82.99 | |||||
| EV-to-Revenue | 3.41 | |||||
| EV-to-FCF | 25.04 | |||||
| Price-to-Projected-FCF | 1.88 | |||||
| Price-to-Median-PS-Value | 0.91 | |||||
| Price-to-Graham-Number | 5.17 | |||||
| Price-to-Net-Current-Asset-Value | 12.49 | |||||
| Price-to-Net-Cash | 102.4 | |||||
| Earnings Yield (Greenblatt) % | 1.2 | |||||
| FCF Yield % | 3.39 | |||||
| Forward Rate of Return (Yacktman) % | -20.98 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Shandong Wohua Pharmaceutical Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ¥) | 769.793 | ||
| EPS (TTM) (Â¥) | 0.04 | ||
| Beta | 0.8 | ||
| Volatility % | 34.42 | ||
| 14-Day RSI | 60.52 | ||
| 14-Day ATR (Â¥) | 0.171837 | ||
| 20-Day SMA (Â¥) | 5.011 | ||
| 12-1 Month Momentum % | -27.68 | ||
| 52-Week Range (Â¥) | 3.2 - 7.22 | ||
| Shares Outstanding (Mil) | 577.21 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Shandong Wohua Pharmaceutical Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Shandong Wohua Pharmaceutical Co Ltd Stock Events
| Event | Date | Price(Â¥) | ||
|---|---|---|---|---|
| No Event Data | ||||
Shandong Wohua Pharmaceutical Co Ltd Frequently Asked Questions
What is Shandong Wohua Pharmaceutical Co Ltd(SZSE:002107)'s stock price today?
The current price of SZSE:002107 is ¥5.12. The 52 week high of SZSE:002107 is ¥7.22 and 52 week low is ¥3.20.
When is next earnings date of Shandong Wohua Pharmaceutical Co Ltd(SZSE:002107)?
The next earnings date of Shandong Wohua Pharmaceutical Co Ltd(SZSE:002107) is .
Does Shandong Wohua Pharmaceutical Co Ltd(SZSE:002107) pay dividends? If so, how much?
The Dividend Yield %  of Shandong Wohua Pharmaceutical Co Ltd(SZSE:002107) is 4.88% (As of Today), Highest Dividend Payout Ratio of Shandong Wohua Pharmaceutical Co Ltd(SZSE:002107) was 6.1. The lowest was 0.2. And the median was 0.57. The  Forward Dividend Yield % of Shandong Wohua Pharmaceutical Co Ltd(SZSE:002107) is 4.88%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers